Politics

Former Insys CEO to plead guilty to opioid kickback scheme

An image of a pen, a tablet and a calculator
Credit: Shutterstock photo

BOSTON, Dec 26 (Reuters) - The former chief executive of Insys Therapeutics Inc has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a powerful opioid medication sold by the company, U.S. prosecutors said on Wednesday.

Michael Babich, who resigned as the Arizona-based drugmaker's CEO in 2015 and was slated to face trial next month, has agreed to plead guilty to conspiracy and mail fraud charges, federal prosecutors in Boston disclosed in a court filing.

OCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

BOSTON, Dec 26 (Reuters) - The former chief executive of Insys Therapeutics Inc has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a powerful opioid medication sold by the company, U.S. prosecutors said on Wednesday.

Michael Babich, who resigned as the Arizona-based drugmaker's CEO in 2015 and was slated to face trial next month, has agreed to plead guilty to conspiracy and mail fraud charges, federal prosecutors in Boston disclosed in a court filing.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Stocks

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More